News

Integer Holdings Marks Presence at Key MedTech Conference

Integer Holdings Marks Presence at Key MedTech Conference

Integer Holdings Corporation to Participate in MedTech Conference

Integer Holdings Corporation (NYSE: ITGR), a notable player in the field of medical device contract development and manufacturing, has announced its involvement in an upcoming MedTech conference. This event, organized by Truist Securities, is set to take place in Boston and promises to be a significant gathering for industry professionals.

Insights into the Conference and Integer's Role

The 2025 Truist Securities MedTech Conference is expected to bring together thought leaders and innovators from various sectors within the medical field. Integer's executive leadership team will engage with attendees through a fireside chat. This informal discussion is scheduled for Tuesday, allowing a closer look at the company's advancements and strategic initiatives at 10:40 a.m. ET.

Accessing the Conference Webcast

For those who cannot attend in person, a live webcast of the presentation will be made available on Integer's official website. Interested parties can find it under the “News & Events” section of the Investor Relations page, ensuring that all stakeholders have the opportunity to stay informed about Integer's evolving narrative.

About Integer Holdings Corporation

Integer Holdings Corporation (NYSE: ITGR) stands as one of the largest manufacturers in the medical device sector, offering development and manufacturing services tailored for various markets, including cardiac rhythm management and neuromodulation. This comprehensive approach emphasizes Integer's commitment to enhancing patient care through innovative, high-quality medical products.

Company Mission and Vision

As a strategic partner to medical device companies and original equipment manufacturers (OEMs), Integer strives to elevate patient outcomes across the globe. Their robust product portfolio features recognized brands such as Greatbatch Medical and Lake Region Medical, reinforcing their position as a trusted industry leader.

Contact Information

Integer encourages inquiries through its designated Investor and Media Relations contacts. For more details, you can reach out to Kristen Stewart for investor relations at 551-337-3973, and for media inquiries, Kelly Butler is available at 469-731-6617. Both contacts can also be emailed for additional information.

Frequently Asked Questions

What is the main focus of Integer Holdings Corporation?

Integer is primarily focused on the design and manufacturing of medical devices, serving various healthcare markets.

When will the MedTech conference take place?

The conference is scheduled for June 17, 2025, in Boston, offering insights from industry leaders.

How can stakeholders access the conference presentation?

A live webcast of the presentation will be available on Integer's website under the Investor Relations section.

What brands are associated with Integer Holdings?

Integer's notable brands include Greatbatch Medical and Lake Region Medical, renowned in the healthcare market.

Who can be contacted for investor inquiries?

Kristen Stewart handles investor relations at Integer, reachable at 551-337-3973.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles